The Recall Desk

State

US Virgin Islands product recalls

73,741 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.

What the numbers show

Total
178
Critical
12
Severe
39
Most recent
2026-10-21

Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.

These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,741 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

39576–39600 of 73919

  • SevereFDA (Drugs)·D-0445-2018·2018-02-28

    Pharmedium Recalls Phenylephrine HCl Injections Due To Sterility Concerns

    Pharmedium Services, LLC is recalling all lots of Phenylephrine HCl in 0.9% Sodium Chloride due to a lack of sterility assurance.

    Product
    Phenylephrine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0462-2018·2018-02-28

    Pharmedium Recalls Vecuronium Bromide Injection Due to Sterility Concerns

    Pharmedium Services, LLC is recalling Vecuronium Bromide in Sterile Water for Injection due to a lack of sterility assurance. The recall covers all lots remaining within expiry nationwide.

    Product
    Vecuronium Bromide in Sterile Water for Injection in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0467-2018·2018-02-28

    Pharmedium Recalls Rocuronium Bromide Due to Sterility Assurance Concerns

    Pharmedium Services, LLC is recalling all Rocuronium Bromide products due to a lack of sterility assurance. The recall covers all strengths, doses, and packaging nationwide.

    Product
    Rocuronium Bromide in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0436-2018·2018-02-28

    Pharmedium Recalls Morphine Sulfate Injection Due to Sterility Concerns

    Pharmedium Services, LLC is recalling all lots of Morphine Sulfate in 0.9% Sodium Chloride nationwide due to a lack of sterility assurance.

    Product
    Morphine Sulfate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0435-2018·2018-02-28

    Pharmedium Recalls Midazolam HCl in 5% Dextrose Due to Sterility Concerns

    Pharmedium Services, LLC is recalling all lots of Midazolam HCl in 5% Dextrose due to a lack of sterility assurance. The recall covers all strengths, doses, and packaging nationwide.

    Product
    Midazolam HCl in 5% Dextrose in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-0589-2018·2018-02-28

    Medtronic Visia AF ICDs Recalled for Potential Therapy Failure

    Medtronic is recalling 951 Visia AF ICDs and CRT-Ds because they may fail to deliver high or low voltage therapy.

    Product
    Implantable Cardioverter Defibrillators (ICDs), Visia AF. Labeled as: a. Visia AF VR ICD DF1 (Product No. DVAB1D1); EXPANSION: b. Visia AF" VR ICD DF4 (Product No. DVAB1D4) Implantable devices that automatically detect and treat episodes of ventricular…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0446-2018·2018-02-28

    Pharmedium Recalls Potassium Chloride in 5% Dextrose Due to Sterility Concerns

    Pharmedium Services, LLC is recalling all lots of Potassium Chloride in 5% Dextrose due to a lack of sterility assurance. The recall covers all strengths, doses, and packaging nationwide.

    Product
    Potassium Chloride in 5% Dextrose in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0454-2018·2018-02-28

    Pharmedium Recalls Glycopyrrolate Due to Lack of Sterility Assurance

    Pharmedium Services, LLC is recalling all strengths and packaging of Glycopyrrolate due to a lack of sterility assurance. The recall covers all lots remaining within their expiry dates nationwide.

    Product
    Glycopyrrolate in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0457-2018·2018-02-28

    Pharmedium Recalls Hydromorphone HCl in 5% Dextrose Due to Sterility Concerns

    Pharmedium Services, LLC is recalling Hydromorphone HCl in 5% Dextrose in all strengths and packaging due to a lack of sterility assurance.

    Product
    HYDROmorphone HCl in 5% Dextrose in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0452-2018·2018-02-28

    Pharmedium Recalls Ketamine HCl Injection Due to Sterility Assurance Concerns

    Pharmedium Services, LLC is recalling all lots of Ketamine HCl Injection because of a lack of sterility assurance. The recall covers all strengths, doses, and packaging distributed nationwide.

    Product
    Ketamine HCl Injection in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-0640-2018·2018-02-28

    GastriSail Gastric Positioning Device Recalled Due to Perforation Reports

    FDA is recalling 17,271 units of the GastriSail Gastric Positioning Device due to reports of gastric or esophageal perforation during surgical procedures.

    Product
    GastriSail" Gastric Positioning Device Product Usage: The GastriSail gastric positioning system is indicated for use in gastric and bariatric surgical procedures for the application of suction, decompression and to radially expand the stomach, to drain gastric fluids, to test…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0440-2018·2018-02-28

    Pharmedium Recalls Potassium Chloride Infusions Due to Sterility Concerns

    Pharmedium Services, LLC is recalling all lots of Potassium Chloride in 0.9% Sodium Chloride due to a lack of sterility assurance.

    Product
    Potassium Chloride in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0430-2018·2018-02-28

    Pharmedium Recalls Fentanyl and Ropivacaine Injection Due to Sterility Concerns

    Pharmedium Services, LLC is recalling Fentanyl Citrate and Ropivacaine HCl injections because of a lack of sterility assurance. The recall covers all lots remaining within their expiry dates nationwide.

    Product
    Fentanyl Citrate and Ropivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0450-2018·2018-02-28

    Pharmedium Recalls Fentanyl Citrate Injection Due to Sterility Concerns

    Pharmedium Services, LLC is recalling Fentanyl Citrate Injection in all strengths and packaging due to a lack of sterility assurance.

    Product
    Fentanyl Citrate Injection in all strengths, all doses, and all packaging.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-0584-2018·2018-02-28

    Medtronic Viva CRT-D Recall for Possible Prevention of Therapy

    Medtronic is recalling 951 Viva CRT-D devices due to a potential issue that may prevent high and low voltage therapy.

    Product
    Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Viva. Labeled as the following: a. Viva Quad S CRT-D DF4 (Product No. DTBB1QQ); b. Viva Quad XT CRT-D DF4 (Product No. DTBA1QQ); c. Viva S CRT-D DF1 (Product No. DTBB1D1); d. Viva XT CRT-D DF1 (Product No.…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0650-2018·2018-02-28

    Arrow International Recalls Multi Lumen Central Venous Catheterization Kits

    Arrow International is recalling 5,926 Multi Lumen Central Venous Catheterization Kits because they may contain the incorrect Springwire Guide.

    Product
    Multi Lumen Central Venous Catheterization Kit; Product Code: ASK-12703-HH2; Exp. Dates Feb 2018 - Nov 2018
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0655-2018·2018-02-28

    Arrow International Recalls Multi Lumen Central Venous Catheterization Kits

    Arrow International Inc is recalling specific lots of AGB+ Multi Lumen Central Venous Catheterization Kits because they may contain the incorrect Springwire Guide.

    Product
    AGB+ Multi Lumen Central Venous Catheterization Kit; Product Codes: CDC-42703-XP1A and CDC-47702-XP1A; Exp. Dates Feb 2018 - Nov 2018
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0685-2018·2018-02-28

    Boston Scientific Recalls Innova Self-Expanding Stent Systems Due to Release Defect

    Boston Scientific is recalling 22,916 units of the Innova Self-Expanding Stent System because the stent may not fully release from the delivery system.

    Product
    Innova Self-Expanding Stent System, 200 mm. Labeled with Material Number and description as follows: Product Usage: The Innova Vascular Self-Expanding Stent System is indicated to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0686-2018·2018-02-28

    Boston Scientific Recalls Innova Self-Expanding Stent Systems Due to Release Defect

    Boston Scientific is recalling 22,916 Innova Self-Expanding Stent Systems because they may not fully release from the delivery system.

    Product
    Innova Self-Expanding Stent System, 180mm. Labeled with Material Number and description as follows: Product Usage: The Innova Vascular Self-Expanding Stent System is indicated to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0643-2018·2018-02-28

    Pentax Video Duodenoscope Recalled to Mitigate Infection Risk

    Pentax of America Inc is recalling 559 Video Duodenoscopes to replace specific components and update inspection protocols to mitigate the potential risk of infection.

    Product
    Pentax Video Duodenoscope Model: ED-3490TK (UDI of design being recalled: 04961333232420) These instruments are intended to provide optical visualization of (via a video monitor), and therapeutic access to, the biliary tract via the upper GI tract. This anatomy includes…
    Category
    Medical Device
    Distribution
    Distributed nationwide